• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Severity assessment and prognostic evaluation of idiopathic dilated cardiomyopathy by measurement of soluble LOX-1

Research Project

Project/Area Number 26461064
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Cardiovascular medicine
Research InstitutionGifu University

Principal Investigator

AOYAMA Takuma  岐阜大学, 大学院医学系研究科, 非常勤講師 (60422713)

Co-Investigator(Renkei-kenkyūsha) MINATOGUCHI Shinya  岐阜大学, 大学院医学系研究科, 教授 (20190697)
SAWAMURA Tatsuya  信州大学, 学術研究院医学系, 教授 (30243033)
NISHIGAKI Kazuhiko  岐阜大学, 医学部附属病院, 准教授 (60198447)
TAKEMURA Genzou  朝日大学, 歯学部, 教授 (40283311)
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Keywords拡張型心筋症 / LOX-1 / 心不全 / sLOX-1
Outline of Final Research Achievements

Severity assessment of dilated cardiomyopathy (DCM) was examined by measurement of sLOX-1. Concentration of soluble LOX-1 were not correlated with BNP and parameters of echocardiography. Next, we focused a question whether LOX-1 contributes to the pathogenesis of DOX-induced cardiomyopathy. Preserved left ventricular function of LOX-1 knockout (KO) mice compared with those of wild (WT) mice was found after DOX administration. Production of ROS, activation of NF-κB, production of TNF-α, expression of VCAM-1, and leukocyte infiltration were observed less in LOX-1 KO mice than WT mice. On the other hand, decreased expression of sarcometric proteins resulted in smaller diameters of CMs in WT mice than in LOX-1 KO mice. Interestingly, expression of LOX-1 in CMs was much more abundant than that in other cells.
LOX-1 in CMs plays the most important roles in the pathology of DOX-induced cardiomyopathy.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (1 results)

All 2016

All Journal Article (1 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results,  Open Access: 1 results)

  • [Journal Article] Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.2016

    • Author(s)
      Yokoyama C, Aoyama T, Ido T, Kakino A, Shiraki T, Tanaka T, Nishigaki K, Hasegawa A, Fujita Y, Sawamura T, Minatoguchi S.
    • Journal Title

      PLoS One

      Volume: 11(5) Issue: 5 Pages: e0154994-e0154994

    • DOI

      10.1371/journal.pone.0154994

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi